We examined the effect of orally administering L-Ser-L-Tyr (SY) dipeptide on the brain of a serine deficiency disease model mouse to attain the efficient delivery of L-Tyr and L-Ser into the mouse brain. Oral SY administration increased the L-Tyr level more efficiently than L-Tyr administration with the same intake dose, but did not significantly affect the L-Ser level when compared with L-Ser administration.Key words: brain; dipeptide; Phgdh; serine; tyrosine It is well established that dysregulation in neurotransmission systems have been thought to underlie psychiatric disorders including schizophrenia.1) L-Tyrosine (L-Tyr) and L-serine (L-Ser) play distinct roles in these neurotransmission systems. Catecholamines comprising dopamine, adrenaline, and noradrenaline are synthesized from L-Tyr, 2) while L-Ser serves as a precursor for the synthesis of D-Ser, an essential coagonist of the N-methyl-D-aspartate (NMDA)-selective glutamate receptors.3) Changes in the availability of L-Tyr and L-Ser in the brain are respectively likely to influence the catecholamine and D-Ser levels.
2)We have recently reported that brain-specific knockout mice (BKO) of D-3-phosphoglycerate dehydrogenase (Phgdh), which catalyzes the first step in the de novo biosynthesis of L-Ser, exhibited marked reductions in both the L-and D-Ser levels in the brain, this being accompanied by a diminished NMDA receptor function. 4) Our study highlighted the maintenance of an abundance of D-Ser by de novo synthesized L-Ser, whereby the NMDA receptor can be activated in the adult mouse brain. Since a reduction of the D-Ser level in the brain has been strongly implicated in the NMDA receptor hypofunction, which is thought to underlie the pathophysiology of schizophrenia, 5) the decreased abundance of L-Ser may contribute to increasing the vulnerability of aberrant glutamatergic transmission and schizophrenia-related phenotypes. A recent study has reported that a family with schizophrenia had a chromosomal translocation, which reduced the expression of PSAT1 encoding phosphoserine aminotransferase 1, the second enzyme involved in de novo L-Ser synthesis.6) Despite exhibiting such differing nervous symptoms as microcephaly, psychomotor retardation, and intractable seizures, patients with a genetic L-Ser deficiency have markedly decreased levels of L-and D-Ser in the cerebrospinal fluid and blood due to a mutation of PHGDH, PSAT1 or PSPH.7) Although oral supplementation of L-and/or D-Ser is a potent therapeutic treatment for these patients, it is known that L-and D-Ser diffuse poorly through the blood-brain barrier.8) There is therefore concern that a high-dose intake of these amino acids may cause an unfavorable side effect such as renal toxicity.
9)Dietary proteins are digested into amino acids or diand tripeptides in the intestines during gastrointestinal transit. The free amino acids are then absorbed by amino acid transporters in the brush border membrane of small intestinal cells, while both di-and tripeptides are absorbed in the peptide form by pe...